Summary
- We reviewed and maintained our UnitedHealth position through its underwriting crisis, recognizing that management’s mispricing of annually renewable policies could be corrected through swift action.
- Our July exit from Novo Nordisk demonstrates our willingness to move on from positions when competitive dynamics deteriorate.
- We made several strategic additions during market weakness including Fast Retailing, Chipotle, Gartner and Adyen.
The following segment was excerpted from the Virtus SGA Global Growth Q3 2025 Commentary.
Portfolio Positioning: Key Moves During Adversity
Mispriced Long-Term Growth: UnitedHealth (UNH)
We reviewed and maintained our UnitedHealth position through its underwriting
Select quarterly mutual fund commentaries.
Read the full article here
